InvestorsHub Logo
Followers 46
Posts 4565
Boards Moderated 0
Alias Born 07/26/2010

Re: RNsidersbuying post# 530

Friday, 04/09/2021 11:14:53 AM

Friday, April 09, 2021 11:14:53 AM

Post# of 608
RIGL 3.27 - added here...Top line data from NIH/NHLBI-sponsored Phase 2 trial of fostamatinib in COVID-19 patients expected in April 2021

https://secfilings.nasdaq.com/filingFrameset.asp?FilingID=14765212&RcvdDate=3/2/2021&CoName=RIGEL%20PHARMACEUTICALS%20INC&FormType=8-K&View=html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RIGL News